Shehnaaz Suliman, Director at 10x Genomics, Inc. (TXG), sold 5,723 shares at $32.59 ($187K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Scheduled sale ($187k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.59 | 5,359 | $175K | 93.5% |
| 2 | $33.27 | 364 | $12K | 6.5% |
| Total | $32.63 avg | 5,723 | $187K | 100% |
| Filing → |
| RARE | SELL | 2026-05-18 | $144K | — | Filing → |
| ALEC | SELL | 2021-12-14 | $6.5M | — | Filing → |
| ALEC | SELL | 2021-12-10 | $6.8M | — | Filing → |